Skip to main content
SpringerLink
Log in

Vitamin D and Prostate Cancer

  • Chapter
Diet and Cancer

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 354))

Abstract

An analysis of the rising incidence and mortality rate of prostate cancer reveals the extraordinary importance of this disease in the world. Adenocarcinoma of the prostate is the most common cancer diagnosed in American males, reaching an estimated incidence of 32%, with 200,000 cases of newly diagnosed cancer cases expected in 1994.1 In addition, clinically inapparent prostate cancer is an extremely common finding. Over the age of 80, subclinical prostate cancer is found in approximately 60% of all men.2 Overall, it is estimated that there are 11 million men in the U.S. with lesions within their prostates that are histologically identifiable as cancer.3 Mortality from prostate cancer represents a considerable problem. It is expected that prostate cancer will account for 13% (38,000 cases) of male cancer deaths in 1994.1 This makes prostate cancer the second leading cause of cancer-related death in U.S. men after lung cancer. Mortality rates from prostate cancer appear to be on the rise. From 1970 to 1990 the age-adjusted mortality rate from prostate cancer increased approximately 7 % among U.S. caucasians. Since prostate cancer rates increase with age, as the longevity of the population increases, it is projected that prostate cancer will become the leading cause of cancer and cancer death in men. These observations demonstrate that prostate cancer is one of the major adverse factors in the health of the male population in the United States and for that matter, in the rest of the world as well.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. C.C. Boring, T.S. Squires, T. Tong, and S. Montgomery, Cancer statistics, 1994, CA Cancer J Clin. 44: 7 (1994).

    Article  PubMed  CAS  Google Scholar 

  2. J.M. Kozlowski, and J.T. Grayhack, Carcinoma of the prostate, in: Adult and Pediatric Urology, J. Y. Gillenwater, J. T. Grayhack, S. S. Howards and J. W. Duckett, eds. Mosby Year Book, St Louis (1991).

    Google Scholar 

  3. H. Carter, and D. Coffey: The magnitude of the problem in the United States., in: A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer., D. Coffey Resnick,M.,Dorr,F., et al., eds. Plenum Press, New York (1988).

    Google Scholar 

  4. L. Cannon, D. Bishop, M. Skolnick, S. Hunt, J. Lyon, and C. Smart, Genetic epidemiology of prostate cancer in the Utah Mormon genealogy., Cancer Survey. 1: 47 (1983).

    Google Scholar 

  5. C. Woolf, An investigation of the familial aspects of carcinoma of the prostate, Cancer. 13: 739 (1960).

    Article  PubMed  CAS  Google Scholar 

  6. W. Meikle, J. Smith, and D. West, Familial factors affecting prostatic cancer risk and plasma steroid levels, Prostate. 6: 121 (1985).

    Article  PubMed  CAS  Google Scholar 

  7. J.D. McConnell, Physiologic basis of endocrine therapy for prostatic cancer, Urol Clin North Amer. 18: 1 (1991).

    CAS  Google Scholar 

  8. P. Ekman, and J. Brolin, Steroid receptor profile in human prostate cancer metastases as compared with primary prostatic carcinoma, Prostate. 18: 147 (1991).

    Article  PubMed  CAS  Google Scholar 

  9. C. Huggins, R.E. Stevens, and C.V. Hodges, Studies on prostatic cancer.II. The effects of castration on advanced carcinoma of the prostate gland, Arch Surg. 43: 209 (1941).

    Article  CAS  Google Scholar 

  10. R.M. Wolf, S.L. Schneider, J.E. Pontes, L. Englander, J.P. Karr, G.P. Murphy, and A.A. Sandberg, Estrogen and progestin receptors in human prostatic carcinoma, Cancer. 55: 2477 (1985).

    Article  PubMed  CAS  Google Scholar 

  11. G.G. Schwartz, and B.S. Hulka, Is Vitamin D deficiency a risk factor for prostate cancer?(Hypothesis), Anticancer Res. 10: 1307 (1990).

    PubMed  CAS  Google Scholar 

  12. C.F. Garland, G.W. Comstock, F.C. Garland, K.J. Helsing, E.K. Shaw, and E.D. Gorham, Serum 25-Hydroxyvitamin D and colon cancer: Eight-year prospective study., Lancet. 2: 1176 (1989).

    Article  PubMed  CAS  Google Scholar 

  13. C.F. Garland, F.C. Garland, and E.D. Gorham, Can colon cancer incidence and death rates be reduced with calcium and vitamin D?, Am J Clin Nutr. 54 (Suppl.1): 193 (1991).

    Google Scholar 

  14. C.L. Hanchette, and G.G. Schwartz, Geographic patterns of prostate cancer mortality: Evidence for a protective effect of ultraviolet radiation, Cancer. 70: 2861 (1992).

    Article  PubMed  CAS  Google Scholar 

  15. R.J. Skowronski, D.M. Peehl, and D. Feldman, Vitamin D and prostate cancer: 1,25 Dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines, Endocrinology. 132: 1952 (1993).

    Article  PubMed  CAS  Google Scholar 

  16. R.J. Skowronski, D.M. Peehl, and D. Feldman, Actions of vitamin D3 analogs on human prostate cancer cell lines: Comparison with 1,25-dihydroxyvitamin D3, Endocrinology 136: 20 (1995).

    Article  PubMed  CAS  Google Scholar 

  17. D.M. Peehl, R.J. Skowronski, G.K. Leung, S.T. Wong, T.A. Stamey, and D. Feldman, Antiproliferative effects of 1,25-Dihydroxyvitamin D3 on primary cultures of human prostatic cells, Cancer Res. 54: 805 (1994).

    PubMed  CAS  Google Scholar 

  18. D. Peehl, R.J. Skowronski, and D. Feldman, Role of vitamin D receptors in prostate cancer, in: Intl. Symp.“Sex Hormones and Antihormones in Endocrine Dependent Pathology: Basic and Clinical Aspects, Elsevier, Amsterdam, in press (1994).

    Google Scholar 

  19. E.H. Corder, H.A. Guess, B.S. Hulka, G.D. Friedman, M. Sadler, R.T. Vollmer, B. Lobaugh, M.K. Drezner, J.h. Vogelman, and N. Orentreich, Vitamin D and prostate cancer: A prediagnostic study with stored sera, Cancer Epidemiology, Biomakers & Prevention. 2: 467 (1993).

    CAS  Google Scholar 

  20. A.W. Norman, J. Roth, and L. Orci, The vitamin D endocrine system: Steroid metabolism, hormone receptors, and biological response (calcium binding proteins)., Endocr Rev. 3: 331 (1982).

    Article  PubMed  CAS  Google Scholar 

  21. J.W. Pike, Vitamin D3 receptors: structure and function in transcription, Ann Rev Nutr. 11: 189 (1991).

    Article  CAS  Google Scholar 

  22. R.M. Evans, The steroid and thyroid hormone receptor superfamily, Science. 240: 889 (1988).

    Article  PubMed  CAS  Google Scholar 

  23. B. O’Malley, The steroid receptor superfamily: more excitement predicted for the future, Mol Endocrinol. 4: 363 (1990).

    Article  PubMed  Google Scholar 

  24. D. Feldman, and P.J. Malloy, Hereditary 1,25 dihydroxyvitamin D resistant rickets: Molecular basis and implications for the role of 1,25(OH)2D3 in normal physiology, Mol Cell Endocrinol. 72: C57 (1990).

    Article  PubMed  CAS  Google Scholar 

  25. G.J. Miller, G.E. Stapleton, J.A. Ferrara, M.S. Lucia, S. Pfister, T.E. Hedlund, and P. Upadhya, The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1a,25-dihydroxyvitamin D3, Cancer Res. 52: 515 (1992).

    PubMed  CAS  Google Scholar 

  26. K. Burton, A study of conditions and mechanisms of the diphenyl amine colorimetric estimation of deoxyribonucleic acid, Biochem J. 62: 315 (1956).

    PubMed  CAS  Google Scholar 

  27. C. Auffray, and F. Rougeon, Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA., Eur JBiochem. 107: 303 (1980).

    Article  CAS  Google Scholar 

  28. A.R. Baker, D.P. McDonnell, M. Hughes, T.M. Crisp, D.J. Mangelsdorf, M.R. Haussier, J.W. Pike, J. Shine, and B.W. O’Malley, Cloning and expression of full-length cDNA encoding human vitamin D receptor., Proc Natl Acad Sci USA. 85: 3294 (1988).

    Article  PubMed  CAS  Google Scholar 

  29. Y. Ohyama, M. Noshiro, and K. Okuda, Cloning and expression of cDNA encoding 25-hydroxyvitamin D3 24-hydroxylase, FEBSLett. 278: 195 (1991).

    Article  PubMed  CAS  Google Scholar 

  30. T.A. Stamey, H.C.B. Graves, N. Wenner, M. Ferrari, and F. Freiha, Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen, J Urol. 149: 787 (1993).

    PubMed  CAS  Google Scholar 

  31. P.J. Malloy, Z. Hochberg, D. Tiosano, J.W. Pike, M.R. Hughes, and D. Feldman, The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families, J Clin Invest. 86: 2071 (1990).

    Article  PubMed  CAS  Google Scholar 

  32. J.W. Pike, Monoclonal antibodies to chick intestinal receptors for 1,25-dihydroxyvitamin D3, J Biol Chem. 259: 1167 (1984).

    PubMed  CAS  Google Scholar 

  33. T.A. Stamey, and J.N. Kabalin, Prostate specific antigen in the diagnosis and teratment of adenocarcinoma of the prostate.I.Untreated patients, J Urol. 141: 1070 (1989).

    PubMed  CAS  Google Scholar 

  34. H.-P. Schmid, J.E. McNeal, and T.A. Stamey, Observations on the doubling time of prostate cancer, Cancer. 71: 2031 (1993).

    Article  PubMed  CAS  Google Scholar 

  35. M.A. Anzano, J.M. Smith, M.R. Uskokovic, C.W. Peer, L.T. Mullen, J.J. Letterio, M.C. Welsh, M.W. Shrader, D.1. Logsdon, C.L. Driver, C.C. Brown, A.R. Roberts, and M.B. Sporn, la,25-Dihydroxy-16ene-23yne-26,27-hexafluorocholecalciferol (Ro24–5531) a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat, Cancer Res. 54: 1653 (1994).

    PubMed  CAS  Google Scholar 

  36. K.W. Colston, A.G. Mackay, S. Chander, L. Binderup, and R.C. Coombes, Novel vitamin D analogues suppress tumor growth in vivo, in: Vitamin D: Gene Regulation, Structure-Function Analysis and Clinical Application: Proceedings of the Eighth Workshop on Vitamin D, Berlin, de Gruyter, 465 (1991).

    Google Scholar 

  37. G. Schleicher, T.H. Privette, and W.E. Stumpf, Distribution of soltriol [1,25(OH)2-Vitamin D3] binding sites in male sex organs of the mouse: An autoradiographic study., J Histochem Cytochem. 37: 1083 (1989).

    Article  PubMed  CAS  Google Scholar 

  38. M.R. Walters, D.L. Cuneo, and A.P. and Jamison, A possible significance of new target tissues for 1,25-dihydroxyvitamin D3, J Steroid Biochem. 19: 913 (1983).

    Article  PubMed  CAS  Google Scholar 

  39. K. Colston, J.M. Colston, Fieldsteel, and D. Feldman, 1,25-Dihydroxyvitamin D3 receptors in human epithelial cancer cell lines, Cancer Res. 42: 856 (1982).

    PubMed  CAS  Google Scholar 

  40. B.C. Osmundsen, H.F.S. Huang, M.B. Anderson, S. Christakos, and M.R. Walters, Multiple sites of action of the vitamin D endocrine system: FSH stimulation of testis 1,25-dihydroxyvitamin D3 receptors, J Steroid Biochem. 34: 339 (1989).

    Article  PubMed  CAS  Google Scholar 

  41. H. Reichel, H.P. Koeffler, and A.W. Norman, The role of the vitamin D endocrine system in health and disease, N Engl J Med. 320: 980 (1989).

    Article  PubMed  CAS  Google Scholar 

  42. W.E. Stumpf, M. Sar, F.A. Reid, and e. al., Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid, Science. 206: 1188 (1979).

    Google Scholar 

  43. E. Abe, C. Miyayra, H. Sakagami, M. Takeda, K. Konno, T. Yamazaki, S. Yoshiki, and T. Suda, Differentiation of mouse myeloid leukemia cells induced by la,25-dihydroxyvitamin D3., Proc NatlAcad Sci USA. 78: 4990 (1981).

    Article  PubMed  CAS  Google Scholar 

  44. K.W. Colston, U. Berger, and R.C. Coombes, Possible role for vitamin D in controlling breast cancer cell proliferation, Lancet. 1:188 (1989).

    Google Scholar 

  45. J.A. Eisman, D.H. Barkla, and P.J. Tutton, Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3, Cancer Res. 47: 21 (1987).

    PubMed  CAS  Google Scholar 

  46. K. Colston, J.M. Colston, and D. Feldman, 1,25-Dihydroxyvitamin D3 and malignant melanoma: The presence of receptors and inhibition of cell growth in culture, Endocrinology. 108: 1083 (1981).

    Article  PubMed  CAS  Google Scholar 

  47. A. Brehier, and M. Thomassat, Human colon cell line HT-29: Characterisation of 1,25-dihydroxyvitamin D3 receptor and induction of differentiation by the hormone, J Steroid Biochem. 29: 265 (1988).

    Article  PubMed  CAS  Google Scholar 

  48. K.D. Harper, R.V. Iozzo, and J.G. Haddad, Receptors for and bioresponses to 1,25-dihydroxyvitamin D in a human colon carcinoma cell line (HT-29), Metabolism. 38: 1062 (1989).

    Article  PubMed  CAS  Google Scholar 

  49. X. Zhao, and D. Feldman, Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells, Endocrinology. 132: 1808 (1993).

    Article  PubMed  CAS  Google Scholar 

  50. P. Lointier, F. Meggouh, P. Dechelotte, D. Pezet, C. Ferrier, J. Chipponi, and S. Saez, 1,25-Dihydroxyvitamin D3 receptors and human colon adenocarcinoma, BrJSurg. 78: 435 (1991).

    Article  PubMed  CAS  Google Scholar 

  51. C.F. Garland, and F.C. Garland, Do vitamin D and sunlight reduce the likelihood of colon cancer?, Int J Epidemiol. 9: 227 (1980).

    Article  PubMed  CAS  Google Scholar 

  52. H.A.P. Pols, J.C. Birkenhager, J.A. Foekens, and J.P.T.M. Van Leeuwen, Vitamin D: A modulator of cell proliferation and differentiation, JSteroid Biochem. 37: 873 (1990).

    CAS  Google Scholar 

  53. T.A. Owen, M.S. Aronow, L.M. Barone, B. Bettencourt, G.S. Stein, and J.B. Lian, Pleitropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phehnotype: Dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in the normal rat osteoblast cultures, Endocrinology. 128: 1496 (1991).

    Article  PubMed  CAS  Google Scholar 

  54. E.M. Costa, H.M. Blau, and D. Feldman, 1,25-dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells, Endocrinology. 119: 2214 (1986).

    Article  PubMed  CAS  Google Scholar 

  55. S. Pillai, D.D. Bikle, and P.M. Elias, 1,25-dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation., JBiol Chem. 263: 5390 (1988).

    CAS  Google Scholar 

  56. T. Suda, T. Shinki, and N. Takahashi, The role of vitamin D in bone and intestinal cell differentiation, Ann Rev Nutr. 10: 195 (1990).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine and Urology (D.M.P.), Stanford University School of Medicine, Stanford, California, 94305-5103, USA

    David Feldman, Roman J. Skowronski & Donna M. Peehl

Authors
  1. David Feldman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roman J. Skowronski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Donna M. Peehl
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 1995 Springer Science+Business Media New York

    About this chapter

    Cite this chapter

    Feldman, D., Skowronski, R.J., Peehl, D.M. (1995). Vitamin D and Prostate Cancer. In: Diet and Cancer. Advances in Experimental Medicine and Biology, vol 354. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0949-7_5

    Download citation

    • DOI: https://doi.org/10.1007/978-1-4899-0949-7_5

    • Publisher Name: Springer, Boston, MA

    • Print ISBN: 978-1-4899-0951-0

    • Online ISBN: 978-1-4899-0949-7

    • eBook Packages: Springer Book Archive

    Publish with us

    Policies and ethics

    Search

    Navigation